Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalipso Chalkidou

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
Bulletin of the World Health Organization|January 7, 2020
Charging for the use of survey instruments on population health: the case of quality-adjusted life yearsYot Teerawattananon, Alia Cg Luz, Anthony Culyer, et al.
F1000Research|September 5, 2017
We need a NICE for global development spendingKalipso Chalkidou, Anthony J Culyer, Amanda Glassman, et al.
Health Research Policy and Systems|September 5, 2020
Capacity for health economics research and practice in Jordan, Lebanon, the occupied Palestinian territories and Turkey: needs assessment and options for developmentAdrian Gheorghe, Mohamed Gad, Sharif A Ismail, et al.
Human Resources for Health|February 19, 2020
Medical training for universal health coverage: a review of Cuba-South Africa collaborationNeil Squires, Susannah E Colville, Kalipso Chalkidou, et al.
F1000Research|December 1, 2021
Health technology assessment capacity at national level in sub-Saharan Africa: an initial survey of stakeholdersSamantha A Hollingworth, Francis Ruiz, Mohamed Gad, et al.
BMJ Global Health|August 4, 2021
The journey to UHC: how well are vertical programmes integrated in the health benefits package? A scoping reviewLydia Regan, David Wilson, Kalipso Chalkidou, et al.
Journal of Health Services Research & Policy|June 25, 2008
Evidence-informed evidence-makingKalipso Chalkidou, Tom Walley, Anthony Culyer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 2, 2021
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?Adrian Towse, Kalipso Chalkidou, Isobel Firth, et al.
Health Policy (Amsterdam, Netherlands)|January 27, 2009
Searching for cost effectiveness thresholds in the NHSJohn Appleby, Nancy Devlin, David Parkin, et al.
Pharmacoeconomics|January 21, 2010
Access with evidence development in the UK: past experience, current initiatives and future potentialAndrew Briggs, Karen Ritchie, Elisabeth Fenwick, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
Bulletin of the World Health Organization|January 7, 2020
Charging for the use of survey instruments on population health: the case of quality-adjusted life yearsYot Teerawattananon, Alia Cg Luz, Anthony Culyer, et al.
F1000Research|September 5, 2017
We need a NICE for global development spendingKalipso Chalkidou, Anthony J Culyer, Amanda Glassman, et al.
Health Research Policy and Systems|September 5, 2020
Capacity for health economics research and practice in Jordan, Lebanon, the occupied Palestinian territories and Turkey: needs assessment and options for developmentAdrian Gheorghe, Mohamed Gad, Sharif A Ismail, et al.
Human Resources for Health|February 19, 2020
Medical training for universal health coverage: a review of Cuba-South Africa collaborationNeil Squires, Susannah E Colville, Kalipso Chalkidou, et al.
F1000Research|December 1, 2021
Health technology assessment capacity at national level in sub-Saharan Africa: an initial survey of stakeholdersSamantha A Hollingworth, Francis Ruiz, Mohamed Gad, et al.
BMJ Global Health|August 4, 2021
The journey to UHC: how well are vertical programmes integrated in the health benefits package? A scoping reviewLydia Regan, David Wilson, Kalipso Chalkidou, et al.
Journal of Health Services Research & Policy|June 25, 2008
Evidence-informed evidence-makingKalipso Chalkidou, Tom Walley, Anthony Culyer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 2, 2021
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?Adrian Towse, Kalipso Chalkidou, Isobel Firth, et al.
Health Policy (Amsterdam, Netherlands)|January 27, 2009
Searching for cost effectiveness thresholds in the NHSJohn Appleby, Nancy Devlin, David Parkin, et al.
Pharmacoeconomics|January 21, 2010
Access with evidence development in the UK: past experience, current initiatives and future potentialAndrew Briggs, Karen Ritchie, Elisabeth Fenwick, et al.
Pageof 15